79344258 - METEOR

Information

• Trademark
• 79344258

• Source

• Serial Number

  79344258

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  November 09, 2021
  3 years ago

• Transaction Date

  January 10, 2025
  a month ago

• Status Date

  January 03, 2025
  2 months ago

• Location Date

  January 03, 2025
  2 months ago

• Status Code

  641

• Current Location

  TMO LAW OFFICE 113

  Employee Name

  MURRAY, TY

• Attorney Docket Number

  262194000004

  Attorney Name

  Karl M. Zielaznicki, Esq.

  Law Office Assigned Location Code

  M40

• Owners

  • Adaptate Biotherapeutics Limited

Case File Statements

• GS0051: Pharmaceuticals, namely, pharmaceutical preparations for the prevention and treatment of human disorders or diseases; antibodies and multi-specific antibodies, namely, colostral antibodies for medical purposes; biotechnological preparations for medical use; capsules sold empty for pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drugs for medical purposes, namely, pharmaceutical products for the prevention and treatment of cancer; injectable pharmaceuticals, namely, pharmaceutical products for the prevention and treatment of cancer; medical preparations and articles, namely, pharmaceutical products for the prevention and treatment of cancer; medicines for human purposes, namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical compositions namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical drugs namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for human use namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for medical purposes namely, pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of anti-infective diseases; pharmaceutical preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of anti-infective diseases; pharmaceuticals preparations namely, pharmaceutical products for the prevention and treatment of cancer; biotechnological preparations for medical use in relation to antibodies and multi-specific antibodies for treating human diseases and disorders; biotechnological preparations for medical use in relation to gamma delta t cells; biotechnological preparations for medical use in relation to immunohistochemistry (IHC) and flow cytometry antibodies for treating human diseases and disorders; chemical preparations for pharmaceutical purposes in relation to antibodies and multi- specific antibodies for treating human diseases and disorders; chemical preparations for pharmaceutical purposes in relation to gamma delta t cells antibodies for treating human diseases and disorders; chemical preparations for pharmaceutical purposes in relation to immunohistochemistry (IHC) and flow cytometry antibodies for treating human diseases and disorders; chemicals for pharmaceutical use in relation to antibodies and multispecific antibodies for treating human diseases and disorders; chemicals for pharmaceutical use in relation to gamma delta t cells antibodies for treating human diseases and disorders; chemicals for pharmaceutical use in relation to immunohistochemistry (IHC) and flow cytometry antibodies for treating human diseases and disorders; drug delivery agents for controlled release of the active ingredients for a wide variety of pharmaceuticals in relation to antibodies and multi-specific antibodies; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals in relation to gamma delta t cells; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals in relation to immunohistochemistry (IHC) and flow cytometry; drugs for medical purposes in relation to antibodies and multi-specific antibodies for treating human diseases and disorders; drugs for medical purposes in relation to gamma delta t cells for treating human diseases and disorders; drugs for medical purposes in relation to immunohistochemistry (IHC) and flow cytometry for treating human diseases and disorders; pharmaceutical preparations in relation to antibodies and multi-specific antibodies for treating human diseases and disorders; pharmaceutical preparations in relation to gamma delta t cells for treating human diseases and disorders; pharmaceutical preparations in relation to immunohistochemistry (IHC) and flow cytometry for treating human diseases and disorders; pharmaceutical preparations in relation to antibodies and multi-specific antibodies for treating human diseases and disorders; pharmaceutical preparations in relation to gamma delta t cells for treating human diseases and disorders; pharmaceutical preparations in relation to immunohistochemistry (IHC) and flow cytometry for treating human diseases and disorders; pharmaceuticals in relation to antibodies and multispecific antibodies for treating human diseases and disorders; pharmaceuticals in relation to gamma delta t cells for treating human diseases and disorders; pharmaceuticals in relation to immunohistochemistry (IHC) and flow cytometry for treating human diseases and disorders; none of the aforesaid goods in relation to agriculture, horticulture or forestry
• GS0011: biological preparations for use in industry and science; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses for scientific, laboratory, medical and medical research use; biological preparations for use in science; monoclonal antibodies for scientific purposes, other than for medical or veterinary use; antibody reagents for scientific purposes; tagged monoclonal antibodies and multi-specific antibodies for scientific use; tagged monoclonal antibodies and multi-specific antibodies for laboratory use; proteins for binding antibodies and multi-specific antibodies for scientific, laboratory, medical and medical research use; proteins for detecting antibodies and multi-specific antibodies for scientific, laboratory, medical and medical research use; biochemical precursors for scientific purposes, namely, precursors for scientific, laboratory, medical and medical research use; biochemical preparations for scientific purposes, namely, precursors for scientific, laboratory, medical and medical research; biochemical reagents used for non-medical purposes; chemical substances, chemical materials and chemical preparations, and natural elements, namely proteins, peptides substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to antibodies and multi-specific antibodies for scientific, laboratory or medical research use; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to antibodies and multi-specific antibodies for scientific, laboratory, medical and medical research use; chemical substances, chemical materials and chemical preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to immunohistochemistry (IHC) and flow cytometry for scientific, laboratory, medical and medical research use; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to immunohistochemistry (IHC) and flow cytometry for scientific, laboratory, medical and medical research use; chemical substances, chemical materials and chemical preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to gamma delta t cells for scientific, laboratory, medical and medical research use; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to gamma delta t cells for scientific, laboratory, medical and medical research use; chemical substances, chemical materials and chemical preparations, and natural elements, namely proteins, peptide substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to immunohistochemistry (IHC) and flow cytometry for scientific, laboratory, medical and medical research use; biological substances, biological materials and biological preparations, and natural elements, namely proteins, peptides substrates, monoclonal antibodies, DNA, RNA, mRNA, cells and viruses in relation to immunohistochemistry (IHC) and flow cytometry for scientific, laboratory, medical and medical research use; chemical compositions and preparations for use in science in relation to antibodies and multispecific antibodies; chemical compositions and preparations for use in science in relation to gamma delta t cells; chemical compositions and preparations for use in science in relation to immunohistochemistry (IHC) and flow cytometry; chemical compositions and preparations for use in science in relation to immunohistochemistry (IHC) and flow cytometry; biological compositions and preparations for use in science in relation to antibodies and multi-specific antibodies; biological compositions and preparations for use in science in relation to gamma delta t cells; biological compositions and preparations for use in science in relation to immunohistochemistry (IHC) and flow cytometry; biological compositions and preparations for use in science in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological precursors for scientific purposes in relation to antibodies and multi-specific antibodies; biochemical and biological precursors for scientific purposes in relation to gamma delta t cells; biochemical and biological precursors for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological precursors for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological preparations for scientific purposes in relation to antibodies and multi-specific antibodies; biochemical and biological preparations for scientific purposes in relation to gamma delta t cells; biochemical and biological preparations for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological preparations for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological reagents used for non-medical purposes in relation to antibodies and multi-specific antibodies; biochemical and biological reagents used for non-medical purposes in relation to gamma delta t cells; biochemical and biological reagents used for non-medical purposes in relation to immunohistochemistry (IHC) and flow cytometry; biochemical and biological reagents used for non-medical purposes in relation to immunohistochemistry (IHC) and flow cytometry; none of the aforesaid goods in relation to agriculture, horticulture or forestry or assays for research purposes
• GS0421: biological research; clinical research in the field of pharmaceuticals; medical research; biomedical research services; clinical trials, namely, scientific research in the nature of conducting clinical trials for others; conducting scientific clinical trials for pharmaceutical products for others; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and development; development of pharmaceutical preparations and medicines; drug discovery services; information technology services for the pharmaceutical and healthcare industries; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; medical and pharmacological research services; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research and development services; pharmaceutical research services; providing information about the results of clinical trials for pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; research and development services in the field of antibodies and multi-specific antibodies; research and development services in the field of antibody technology; scientific research relating to medicines; research and development in the field of medical diagnostic preparations; biological research, clinical research and medical research in relation to antibodies and multi-specific antibodies; biological research, clinical research and medical research in relation to gamma delta t cells; biological research, clinical research and medical research in relation to immunohistochemistry (IHC) and flow cytometry; consultancy relating to pharmaceutical research and development in relation to antibodies and multi-specific antibodies; consultancy relating to pharmaceutical research and development in relation to gamma delta t cells; consultancy relating to pharmaceutical research and development in relation to immunohistochemistry (IHC) and flow cytometry; laboratory research services relating to pharmaceuticals in relation to antibodies and multi-specific antibodies; laboratory research services relating to pharmaceuticals in relation to gamma delta t cells; laboratory research services relating to pharmaceuticals in relation to immunohistochemistry (IHC) and flow cytometry; medical and pharmacological research services in relation to antibodies and multi-specific antibodies; medical and pharmacological research services in relation to gamma delta t cells; medical and pharmacological research services in relation to immunohistochemistry (IHC) and flow cytometry; pharmaceutical research and development services in relation to antibodies and multi-specific antibodies; pharmaceutical research and development services in relation to gamma delta t cells; pharmaceutical research and development services in relation to immunohistochemistry (IHC) and flow cytometry; scientific and technological services in relation to scientific research in the field of antibodies and multi-specific antibodies; scientific and technological services in relation scientific research in the field of gamma delta t cells; scientific and technological services in relation scientific research in the field of immunohistochemistry (IHC) and flow cytometry; scientific research and development in relation to antibodies and multi-specific antibodies; scientific research and development in relation to gamma delta t cells; scientific research and development in relation to immunohistochemistry (IHC) and flow cytometry; information, advisory and consultancy services relating the aforesaid services, and none of the aforesaid services in relation to agriculture, horticulture or forestry

Case File Event Statements

• 7/7/2022 - 2 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 7/8/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 7/12/2022 - 2 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 8/19/2022 - 2 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 8/23/2022 - 2 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/24/2022 - 2 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 9/30/2022 - 2 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 9/30/2022 - 2 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 10/26/2022 - 2 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 2/4/2023 - 2 years ago

  10 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD

• 3/29/2023 - a year ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/29/2023 - a year ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/30/2023 - a year ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/20/2023 - a year ago

  14 - SUSPENSION LETTER WRITTEN Type: CNSL

• 4/20/2023 - a year ago

  15 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 4/20/2023 - a year ago

  16 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 10/18/2023 - a year ago

  17 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 12/13/2023 - a year ago

  19 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 12/13/2023 - a year ago

  18 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 1/2/2024 - a year ago

  20 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 5/31/2024 - 9 months ago

  22 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 11/25/2024 - 3 months ago

  23 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 1/3/2025 - 2 months ago

  25 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/3/2025 - 2 months ago

  26 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 1/3/2025 - 2 months ago

  24 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/16/2024 - 10 months ago

  21 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC